513 related articles for article (PubMed ID: 28087362)
1. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
2. Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.
Eyries M; Montani D; Nadaud S; Girerd B; Levy M; Bourdin A; Trésorier R; Chaouat A; Cottin V; Sanfiorenzo C; Prevot G; Reynaud-Gaubert M; Dromer C; Houeijeh A; Nguyen K; Coulet F; Bonnet D; Humbert M; Soubrier F
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30578383
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
Chaisson NF; Dodson MW; Elliott CG
Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
[TBL] [Abstract][Full Text] [Related]
4. Genetics of pulmonary hypertension in the clinic.
Girerd B; Lau E; Montani D; Humbert M
Curr Opin Pulm Med; 2017 Sep; 23(5):386-391. PubMed ID: 28661905
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary capillary haemangiomatosis: a distinct entity?
Weatherald J; Dorfmüller P; Perros F; Ghigna MR; Girerd B; Humbert M; Montani D
Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32461209
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary capillary hemangiomatosis in Chinese patients without EIF2AK4 mutations.
Li Y; Gu Y; Hong C; Deng Y; Chen Z; Jiang J
Pathol Res Pract; 2020 Sep; 216(9):153100. PubMed ID: 32825965
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary veno-occlusive disease.
Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
[TBL] [Abstract][Full Text] [Related]
8. Variable Expressivity of a Founder Mutation in the EIF2AK4 Gene in Hereditary Pulmonary Veno-occlusive Disease and Its Impact on Survival.
Navas Tejedor P; Palomino Doza J; Tenorio Castaño JA; Enguita Valls AB; Rodríguez Reguero JJ; Martínez Meñaca A; Hernández González I; Bueno Zamora H; Lapunzina Badía PD; Escribano Subías P
Rev Esp Cardiol (Engl Ed); 2018 Feb; 71(2):86-94. PubMed ID: 28697925
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and survival of Chinese patients diagnosed with pulmonary arterial hypertension who carry BMPR2 or EIF2KAK4 variants.
Zeng Q; Yang H; Liu B; Ma Y; Liu Z; Chen Q; Li W; Luo Q; Zhao Z; Zhou Z; Xiong C
BMC Pulm Med; 2020 May; 20(1):150. PubMed ID: 32471403
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary vascular remodeling patterns and expression of general control nonderepressible 2 (GCN2) in pulmonary veno-occlusive disease.
Nossent EJ; Antigny F; Montani D; Bogaard HJ; Ghigna MR; Lambert M; Thomas de Montpréville V; Girerd B; Jaïs X; Savale L; Mercier O; Fadel E; Soubrier F; Sitbon O; Simonneau G; Vonk Noordegraaf A; Humbert M; Perros F; Dorfmüller P
J Heart Lung Transplant; 2018 May; 37(5):647-655. PubMed ID: 29108819
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
[TBL] [Abstract][Full Text] [Related]
12. [Familial pulmonary veno-occlusive disease with a composite biallelic heterozygous EIF2AK4 mutation].
Treffel G; Guillaumot A; Gomez E; Eyries M; Petit I; Chabot JF; Chaouat A
Rev Mal Respir; 2020 Dec; 37(10):823-828. PubMed ID: 33071063
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Characterization of
Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
[TBL] [Abstract][Full Text] [Related]
14. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
Miura A; Akagi S; Nakamura K; Ohta-Ogo K; Hashimoto K; Nagase S; Kohno K; Kusano K; Ogawa A; Matsubara H; Toyooka S; Oto T; Ohtsuka A; Ohe T; Ito H
Cardiovasc Pathol; 2013; 22(4):287-93. PubMed ID: 23312620
[TBL] [Abstract][Full Text] [Related]
15. Genetic counselling in a national referral centre for pulmonary hypertension.
Girerd B; Montani D; Jaïs X; Eyries M; Yaici A; Sztrymf B; Savale L; Parent F; Coulet F; Godinas L; Lau EM; Tamura Y; Sitbon O; Soubrier F; Simonneau G; Humbert M
Eur Respir J; 2016 Feb; 47(2):541-52. PubMed ID: 26699722
[TBL] [Abstract][Full Text] [Related]
16. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
Ogawa A; Takahashi Y; Matsubara H
J Cardiol; 2018 Sep; 72(3):255-260. PubMed ID: 29548663
[TBL] [Abstract][Full Text] [Related]
17. Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease.
Montani D; Lau EM; Descatha A; Jaïs X; Savale L; Andujar P; Bensefa-Colas L; Girerd B; Zendah I; Le Pavec J; Seferian A; Perros F; Dorfmüller P; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2015 Dec; 46(6):1721-31. PubMed ID: 26541523
[TBL] [Abstract][Full Text] [Related]
18. EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
Best DH; Sumner KL; Smith BP; Damjanovich-Colmenares K; Nakayama I; Brown LM; Ha Y; Paul E; Morris A; Jama MA; Dodson MW; Bayrak-Toydemir P; Elliott CG
Chest; 2017 Apr; 151(4):821-828. PubMed ID: 27884767
[TBL] [Abstract][Full Text] [Related]
19. Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations.
Montani D; Dorfmüller P; Girerd B; Le Pavec J; Fadel E; Simonneau G; Sitbon O; Humbert M
Am J Respir Crit Care Med; 2018 Aug; 198(4):537-541. PubMed ID: 29702008
[No Abstract] [Full Text] [Related]
20. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension.
Eyries M; Montani D; Girerd B; Perret C; Leroy A; Lonjou C; Chelghoum N; Coulet F; Bonnet D; Dorfmüller P; Fadel E; Sitbon O; Simonneau G; Tregouët DA; Humbert M; Soubrier F
Nat Genet; 2014 Jan; 46(1):65-9. PubMed ID: 24292273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
